Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond
- PMID: 35882613
- DOI: 10.1016/j.jjcc.2022.07.003
Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond
Abstract
Owing to recent advances in early reperfusion strategies, pharmacological therapy, standardized care, and the identification of vulnerable patient subsets, the prognosis of acute myocardial infarction has improved. However, there is still considerable room for improvement. This review article summarizes the latest evidence concerning clinical diagnosis and treatment of acute myocardial infarction.
Keywords: Acute myocardial infarction; Medical therapy; Percutaneous coronary intervention.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest Satoshi Yasuda reports honoraria from Daiichi Sankyo Co. Ltd. and Bayer Yakuhin, Ltd., research grants from NEC Solution Innovators, Ltd., Daiichi Sankyo Co. Ltd., Bayer Yakuhin, Ltd. Abbott Medical Japan LLC, Medtronic Japan Co., Ltd., Tesco Co. Ltd., Terumo Co., Nihon Kohden Co, Japan Lifeline Co., Ltd., Sound Wave Innovation CO., LTD., ONO PHARMACEUTICAL CO., LTD., SHIONOGI & CO., LTD., ZEON MEDICAL INC., Nippon Shinyaku Co., Ltd., Nippon Boehringer Ingelheim Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Company, Ltd., Takeda Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., and BIOTRONIK JAPAN Co. Ltd., and scholarship grants from Abbott Medical Japan LLC, Amicus Therapeutics Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Company, Ltd., Sumitomo Dainippon Pharma Co., Ltd., and Roche Diagnostics K.K. Other authors report no conflicts of interest to disclose.
Similar articles
-
Reperfusion strategies in acute coronary syndromes.Circ Res. 2014 Jun 6;114(12):1918-28. doi: 10.1161/CIRCRESAHA.114.302744. Circ Res. 2014. PMID: 24902975 Review.
-
Arrhythmias following revascularization procedures in the course of acute myocardial infarction: are they indicators of reperfusion or ongoing ischemia?ScientificWorldJournal. 2013;2013:160380. doi: 10.1155/2013/160380. Epub 2013 Jan 31. ScientificWorldJournal. 2013. PMID: 23431252 Free PMC article. Clinical Trial.
-
Examination of the appropriate timing of reperfusion therapy for recent myocardial infarction: a Japanese single-center retrospective study.Indian Heart J. 2018 Jan-Feb;70(1):4-9. doi: 10.1016/j.ihj.2017.06.015. Epub 2017 Jun 30. Indian Heart J. 2018. PMID: 29455786 Free PMC article.
-
Reperfusion strategies in ST-segment elevation myocardial infarction.Minerva Med. 2013 Aug;104(4):391-411. Minerva Med. 2013. PMID: 24008602 Review.
-
[Cardiac ruptures in acute myocardial infarction].Angiol Sosud Khir. 2021;27(2):185-192. doi: 10.33529/ANGIO2021205. Angiol Sosud Khir. 2021. PMID: 34166360 Russian.
Cited by
-
From Atherosclerotic Plaque to Myocardial Infarction-The Leading Cause of Coronary Artery Occlusion.Int J Mol Sci. 2024 Jul 2;25(13):7295. doi: 10.3390/ijms25137295. Int J Mol Sci. 2024. PMID: 39000400 Free PMC article. Review.
-
Safflower Yellow Injection Alleviates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative and Endoplasmic Reticulum Stress.Pharmaceuticals (Basel). 2024 Aug 12;17(8):1058. doi: 10.3390/ph17081058. Pharmaceuticals (Basel). 2024. PMID: 39204163 Free PMC article.
-
Impact of sodium‒glucose cotransporter-2 inhibitors in patients with recent versus previous myocardial infarction: a systematic review and meta-analysis.Cardiovasc Diabetol. 2025 Feb 13;24(1):73. doi: 10.1186/s12933-024-02540-4. Cardiovasc Diabetol. 2025. PMID: 39948563 Free PMC article.
-
IgD-CD38br lymphocyte affect myocardial infarction by regulating the glycerol to palmitoylcarnitine (C16) ratio: A Mendelian randomization study.Medicine (Baltimore). 2024 Dec 13;103(50):e40871. doi: 10.1097/MD.0000000000040871. Medicine (Baltimore). 2024. PMID: 39686473 Free PMC article.
-
Association between segmental noninvasive longitudinal strain and quantitative microvascular perfusion in ST-segment elevation myocardial infarction: implications for clinical outcomes.BMC Cardiovasc Disord. 2025 Feb 18;25(1):109. doi: 10.1186/s12872-025-04547-5. BMC Cardiovasc Disord. 2025. PMID: 39966701 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
